Article Versions Notes

Rubin E, Pippione AC, Boyko M, Einaudi G, Sainas S, Collino M, Cifani C, Lolli ML, Abu-Freha N, Kaplanski J, et al. A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats. Brain Sciences. 2022; 12(1):35. https://doi.org/10.3390/brainsci12010035

Rubin, Elina, Agnese C. Pippione, Matthew Boyko, Giacomo Einaudi, Stefano Sainas, Massimo Collino, Carlo Cifani, Marco L. Lolli, Naim Abu-Freha, Jacob Kaplanski, and et al. 2022. "A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats" Brain Sciences 12, no. 1: 35. https://doi.org/10.3390/brainsci12010035

Rubin, E., Pippione, A. C., Boyko, M., Einaudi, G., Sainas, S., Collino, M., Cifani, C., Lolli, M. L., Abu-Freha, N., Kaplanski, J., Boschi, D., & Azab, A. N. (2022). A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats. Brain Sciences, 12(1), 35. https://doi.org/10.3390/brainsci12010035